Bristol-Myers Squibb (BMY) Announces Statistically Significant Data from Opdivo Phase 3 in Squamous Cell Carcinoma
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced new patient-reported quality-of-life data from an exploratory endpoint in the pivotal Phase 3 CheckMate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
